UCA1 and non-small cell lung carcinoma: Furthermore, the positive effect of UCA1 on NSCLC cell proliferation was attributed to sponging of miR-193a-3p, and the administration of miR-193a-3p blocked the effect of UCA1 by targeting ERBB4 [41].